Figure 1.
Proportion of treatment-naïve subjects who achieved <50 or <400 HIV-RNA copies/mL after 12 and 24 months of treatment with ABC/3TC containing regimen. (a) All treatment-naïve HIV + subjects, (b) treatment-naïve subjects with baseline pVL <100 000 RNA copies/mL, and (c) treatment-naïve subjects with baseline pVL >100 000 RNA copies/mL. Note that the denominators are those who were on Epzicom treatment for the given duration, therefore not including those who stopped Epzicom earlier